Quantumzyme Corp. (QTZM)

Market Cap	8.18M
Revenue	n/a
Net Income	n/a
Shares Out	38.96M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	10,006
Open	0.3000
Previous Close	0.3000
Day's Range	0.2100 - 0.3000
52-Week Range	0.0025 - 1.9100
Beta	-7.49
RSI	54.96
Earnings Date	n/a

About Regulus Therapeutics

Quantumzyme Corp. operates as a biotransformation company. It develops engineered enzymes for use in active pharmaceutical ingredients production. The company was formerly known as Reliant Services, Inc. and changed its name to Quantumzyme Corp. in March 2023. The company was incorporated in 2015 and is based in San Diego, California.

• Industry: Water, Sewer, Pipeline, and Communications and Power Line Construction
• Founded: 2015
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: QTZM